SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Common Stock, Convertible, Conversion Price, Decrease
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Common Stock, Convertible, Conversion Price, Decrease of $32.00 per share for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-09-04.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2024-09-04
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. common stock, convertible, conversion price, decrease for fiscal 2022 was $32.00.
| Period end | Common Stock, Convertible, Conversion Price, Decrease | Common Stock, Convertible, Conversion Price, Decrease 1 month | Common Stock, Convertible, Conversion Price, Decrease 9 month | Common Stock, Convertible, Conversion Price, Decrease 12 month | Common Stock, Convertible, Conversion Price, Decrease 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $32.00 10-K/A · filed 2024-09-04 | $12.49 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $12.49 10-Q · filed 2022-11-14 | ||||
| 2022-08-31 | $32.50 10-K/A · filed 2024-09-04 | ||||
| 2022-08-01 | $32.00 10-K/A · filed 2024-09-04 | ||||
| 2022-04-30 | $32.00 10-K/A · filed 2024-09-04 | ||||
| 2021-12-28 | $40.00 10-K/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |